ABOUT US
Management
Board of Directors
PIPELINE
Overview
Research & Development
IDO Pathway Inhibitors
COLLABORATION
Industry
Advocacy
CAREERS
Culture
Benefits
Jobs
INVESTORS & MEDIA
Investor Relations
Press Releases
Events & Presentations
Posters & Publications
Corporate Governance
Management
Board of Directors
Contact the Board
Financial Information
SEC Filings
Quarterly Results
Analyst Coverage
Investor FAQs
Contact us
PIPELINE
Discover our latest research on IDO pathway inhibitors, indoximod and NLG802
Read More
MANAGEMENT
Meet our dedicated team of professionals
Read More
INVESTORS
Find up-to-date financial data and latest press releases
Read More
Press Releases
More releases
<!--
Important Links
IMPRESS Phase 3 trial in pancreatic cancer
IDO Pathway Inhibitor
Infectious Disease
San Antonio Breast Cancer Symposium 2015 poster
--!>